Historical record - last NADAC effective date: 11/18/2020
Product Information
IRBESARTAN 150 MG TABLET is a generic product labeled by Hisun Pharmaceuticals USA Inc., priced at $0.2340 per EA under NDC 42658012201. Its NADAC has been published 67 times since Aug 28, 2019.
FDA first approved this application on Jun 14, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Hisun Pharmaceuticals USA Inc.NDC
42658012201
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
11/18/2020
Active Ingredients
IRBESARTANApproval Type
Generic (ANDA)
FDA Application
ANDA206194FDA Approved
6/14/2016
TE Code
AB
On Market Since
4/15/2017
Pharmacological Classes
Price Statistics
The NADAC for IRBESARTAN 150 MG TABLET has been published 67 times since Aug 28, 2019, and over the history we have for it it has declined 14.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2340 per EA |
|---|---|
| All-time high | $0.3249 (Oct 16, 2019) |
| All-time low | $0.2340 (Nov 18, 2020) |
| Median price | $0.2686 |
| Average price | $0.2703 |
| Largest weekly change | +18.2% (Sep 18, 2019) |
| Weeks tracked | 67 |
| Tracking since | Aug 28, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-14.9%
Last surveyed Dec 2, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 53% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IRBESARTAN 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IRBESARTAN 150 MG TABLET, manufactured by Hisun Pharmaceuticals USA Inc., is $0.2340 per EA (NDC 42658012201), effective Dec 2, 2020.
How has the price of IRBESARTAN 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for IRBESARTAN 150 MG TABLET has declined 14.9%. It has been tracked across 67 weekly CMS publications since Aug 28, 2019.
What are the highest and lowest recorded NADAC prices for IRBESARTAN 150 MG TABLET?
Since Aug 28, 2019, the NADAC for IRBESARTAN 150 MG TABLET has ranged from a low of $0.2340 (Nov 18, 2020) to a high of $0.3249 (Oct 16, 2019), with a median of $0.2686 per EA.
Are there cheaper alternatives to IRBESARTAN 150 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IRBESARTAN 150 MG TABLET, is $0.1109 per EA — about 53% below IRBESARTAN 150 MG TABLET.
Who manufactures IRBESARTAN 150 MG TABLET?
IRBESARTAN 150 MG TABLET (NDC 42658012201) is labeled by Hisun Pharmaceuticals USA Inc., and CMS classifies it as a generic product.